Media Advisory

Wednesday, October 4, 2006

Dr. Barry R. Bloom Delivers Barmes Global Health Lecture on December 4, 2006


The National Institute of Dental and Craniofacial Research and the Fogarty International Center, both part of the National Institutes of Health, jointly announce the 2006 David E. Barmes Global Health Lecture. Barry R. Bloom, Ph.D., Dean of the Harvard School of Public Health and Joan L. and Julius H. Jacobson Professor of Public Health, will present a talk entitled, "Agendas and Architecture of Global Health Research."


Monday, December 4, 2006, from Noon to 1:00 p.m., in Masur Auditorium, NIH Building 10, Bethesda, Maryland USA. The event is free and open to the public; it will be videocast live at Light refreshments will be available after the presentation.


This annual lecture series honors the late David E. Barmes, a long-standing World Health Organization employee, special expert for international health in the NIDCR Office of International Health, and ardent spokesman for global health. The series was established in 2001 to honor his lifelong dedication to research as a means to improve health for those in low-income countries.

Barry R. Bloom, Ph.D., is widely recognized as a scientist in the areas of infectious diseases, vaccines and international health. He served as a consultant to the White House on International Health Policy from 1977 to 1978, was elected President of the American Association of Immunologists in 1984, and served as President of the Federation of American Societies for Experimental Biology in 1985. He was a member of the National Advisory Council of the National Institute for Allergy and Infectious Diseases at the National Institutes of Health (NIH), the National Advisory Board of the Fogarty International Center at the NIH, the U.S. National Vaccine Advisory Committee, and the Scientific Advisory Board of the National Center for Infectious Diseases of the Centers for Disease Control and Prevention. In addition, Bloom was an Investigator at the Howard Hughes Medical Institute. He received the first Bristol-Myers Squibb Award for Distinguished Research in Infectious Diseases, the John Enders Award of the Infectious Diseases Society of America in 1994, and shared the Novartis Award in Immunology in 1998.

He is currently a member of the Ellison Medical Foundation Scientific Advisory Board, the Earth Institute External Advisory Board at Columbia University, the Scientific Advisory Board of the Wellcome Trust Center for Human Genetics in Oxford, UK, and the Advisory Council for the Paul G. Rogers Society for Global Health Research. He is a member of the National Academy of Sciences, the Institute of Medicine, the American Academy of Arts and Sciences, and the American Philosophical Society.

The National Institute of Dental and Craniofacial Research is the nation's leading funder of research on oral, dental, and craniofacial health. For more information, visit the Web site at

FIC (, the international component of the NIH, addresses global health challenges through innovative and collaborative research and training programs and supports and advances the NIH mission through international partnerships.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit

NIH…Turning Discovery Into Health®